WebSite > Shanghai Lebeishi Biotechnology Co., LTD

Shanghai Lebeishi Biotechnology Co., LTD

  • Company Name Shanghai Lebeishi Biotechnology Co., LTD
  • Tel 
  • Email labex-mkt@univ-bio.com
  • WebSite www.u-labex.com/
  • CB Index 58
  •       Shanghai lebeishi Biotechnology Co., Ltd. (lebeishi for short) is a wholly-owned subsidiary of UnionPay. It is an experimental service expert mainly focusing on providing single / multi factor correlation detection and analysis in China. At present, it has expanded to multi-color flow detection services and multi-color histochemical detection services. Labex was established in 2018, formerly known as the UnionPay laboratory service division established in 2015, and headquartered in Shanghai. Since its establishment, labex has been seeking breakthroughs. At present, it has developed into a professional and comprehensive laboratory technology platform at the level of genes, cells, proteins and tissues with mature sample preparation, storage, management, transportation, detection, data analysis and other services. We have strict laboratory management processes, standardized laboratory operations, original data storage system and experimental project optimization system. At present, we have 12 technical platforms, including PCR array, ELISA, MSD, Luminex, CBA, antibody chip, flow cytometry and immunohistochemistry. We have served more than 2000 customers offline and online, with more than 250000 annual test samples, which have been appreciated by our customers. Labex inherits the positive, good and upward values of UnionPay. Our vision is "speed up research through service", striving to provide professional, comprehensive and safe laboratory services for our customers, and becoming your right-hand man in scientific research!
Shanghai Lebeishi Biotechnology Co., LTD Product List
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •